
Sclerotherapy Global Market Report 2025
Description
Sclerotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sclerotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for sclerotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sclerotherapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Liquid Sclerotherapy; Foam Sclerotherapy; Ultrasound-Guided Sclerotherapy
2) By Agents: Detergents; Chemical Irritants; Osmotic Agents
3) By Application: Varicose Veins; Spider Veins; Hemorrhoids
4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) By Liquid Sclerotherapy: Polidocanol-based, Sodium Tetradecyl Sulfate (STS)-based, Hypertonic Saline-based
2) By Foam Sclerotherapy: Polidocanol Foam, STS Foam, Air-based Foam
3) By Ultrasound-Guided Sclerotherapy: Foam-guided, Liquid-guided, Combination Therapies
Companies Mentioned: Bayer AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on sclerotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sclerotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sclerotherapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Liquid Sclerotherapy; Foam Sclerotherapy; Ultrasound-Guided Sclerotherapy
2) By Agents: Detergents; Chemical Irritants; Osmotic Agents
3) By Application: Varicose Veins; Spider Veins; Hemorrhoids
4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) By Liquid Sclerotherapy: Polidocanol-based, Sodium Tetradecyl Sulfate (STS)-based, Hypertonic Saline-based
2) By Foam Sclerotherapy: Polidocanol Foam, STS Foam, Air-based Foam
3) By Ultrasound-Guided Sclerotherapy: Foam-guided, Liquid-guided, Combination Therapies
Companies Mentioned: Bayer AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Sclerotherapy Market Characteristics
- 3. Sclerotherapy Market Trends And Strategies
- 4. Sclerotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Sclerotherapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Sclerotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Sclerotherapy Market Growth Rate Analysis
- 5.4. Global Sclerotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Sclerotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Sclerotherapy Total Addressable Market (TAM)
- 6. Sclerotherapy Market Segmentation
- 6.1. Global Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Liquid Sclerotherapy
- Foam Sclerotherapy
- Ultrasound-Guided Sclerotherapy
- 6.2. Global Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Detergents
- Chemical Irritants
- Osmotic Agents
- 6.3. Global Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Varicose Veins
- Spider Veins
- Hemorrhoids
- 6.4. Global Sclerotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Other End-Users
- 6.5. Global Sclerotherapy Market, Sub-Segmentation Of Liquid Sclerotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polidocanol-Based
- Sodium Tetradecyl Sulfate (STS)-Based
- Hypertonic Saline-Based
- 6.6. Global Sclerotherapy Market, Sub-Segmentation Of Foam Sclerotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polidocanol Foam
- STS Foam
- Air-Based Foam
- 6.7. Global Sclerotherapy Market, Sub-Segmentation Of Ultrasound-Guided Sclerotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Foam-Guided
- Liquid-Guided
- Combination Therapies
- 7. Sclerotherapy Market Regional And Country Analysis
- 7.1. Global Sclerotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Sclerotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Sclerotherapy Market
- 8.1. Asia-Pacific Sclerotherapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Sclerotherapy Market
- 9.1. China Sclerotherapy Market Overview
- 9.2. China Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Sclerotherapy Market
- 10.1. India Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Sclerotherapy Market
- 11.1. Japan Sclerotherapy Market Overview
- 11.2. Japan Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Sclerotherapy Market
- 12.1. Australia Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Sclerotherapy Market
- 13.1. Indonesia Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Sclerotherapy Market
- 14.1. South Korea Sclerotherapy Market Overview
- 14.2. South Korea Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Sclerotherapy Market
- 15.1. Western Europe Sclerotherapy Market Overview
- 15.2. Western Europe Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Sclerotherapy Market
- 16.1. UK Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Sclerotherapy Market
- 17.1. Germany Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Sclerotherapy Market
- 18.1. France Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Sclerotherapy Market
- 19.1. Italy Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Sclerotherapy Market
- 20.1. Spain Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Sclerotherapy Market
- 21.1. Eastern Europe Sclerotherapy Market Overview
- 21.2. Eastern Europe Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Sclerotherapy Market
- 22.1. Russia Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Sclerotherapy Market
- 23.1. North America Sclerotherapy Market Overview
- 23.2. North America Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Sclerotherapy Market
- 24.1. USA Sclerotherapy Market Overview
- 24.2. USA Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Sclerotherapy Market
- 25.1. Canada Sclerotherapy Market Overview
- 25.2. Canada Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Sclerotherapy Market
- 26.1. South America Sclerotherapy Market Overview
- 26.2. South America Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Sclerotherapy Market
- 27.1. Brazil Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Sclerotherapy Market
- 28.1. Middle East Sclerotherapy Market Overview
- 28.2. Middle East Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Sclerotherapy Market
- 29.1. Africa Sclerotherapy Market Overview
- 29.2. Africa Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Sclerotherapy Market Competitive Landscape And Company Profiles
- 30.1. Sclerotherapy Market Competitive Landscape
- 30.2. Sclerotherapy Market Company Profiles
- 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 31. Sclerotherapy Market Other Major And Innovative Companies
- 31.1. Medtronic plc
- 31.2. Boston Scientific Corporation
- 31.3. Olympus Corporation
- 31.4. Smith & Nephew plc
- 31.5. Teleflex Incorporated
- 31.6. Cook Medical
- 31.7. Merz Pharma GmbH & Co. KGaA
- 31.8. AngioDynamics Inc.
- 31.9. Bioniche Pharma Group Ltd
- 31.10. Omega Pharmaceuticals Pvt. Ltd.
- 31.11. Endo-Flex
- 31.12. Kreussler
- 31.13. Vascular Solutions, Inc.
- 31.14. LGM Pharma
- 31.15. BTG International Ltd.
- 32. Global Sclerotherapy Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Sclerotherapy Market
- 34. Recent Developments In The Sclerotherapy Market
- 35. Sclerotherapy Market High Potential Countries, Segments and Strategies
- 35.1 Sclerotherapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Sclerotherapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Sclerotherapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.